Facebook parent Meta has been order by the U.K.’s competition watchdog to sell GIF-sharing platform Giphy, which it bought in 2020 for a reported $400 million.

ImmunoGen said the data would be submitted to the U.S. Food & Drug Administration as party of the agency's' Biologics License Application process in the first quarter of next year.

Amid the chip shortage, two key equipment stocks fly under the radar: Lam Research and KLA.

Merck’s Covid-19 oral antiviral pill will be reviewed by an outside panel of advisors to the FDA on Tuesday, paving the way for potential authorization by year-end.

Moderna said its Covid vaccine would likely experience a 'material drop' in efficacy against Omicron, while Regeneron warned its antibody cocktail may also have reduced activity against the new variant.

Stocks slump as Omicron concerns resurface; Moderna CEO cautions on vaccine efficacy against new variant; Powell and Yellen to testify before the Senate Banking Committee on CARES Act; FTC orders supply chain probe and cloud adoption software group HashiCorp seeks $13 billion valuation in upcoming Nasdaq IPO.

Jim Cramer reminds investors that the Omicron Covid variant doesn't pose systemic risks to the markets.

Lululemon seeks injunction in leggings and sports bra design dispute with Peloton.

Twitter's departing CEO has maintained a detached view of his wealth and has donated a lot of it.

Airlines, cruise lines and other travel companies are throwing down Cyber Week deals in the face of new Omicron worries and travel restrictions.